Notable Downgrades: Oasis Petroleum (OAS), (CRM), Northern Oil and Gas (NOG), Sucampo Pharma (SCMP), IBM (IBM )

Analysts at Guggenheim downgraded Oasis Petroleum Inc. (OAS) from ‘Buy‘ to ‘Neutral‘ in a research report issued to clients on Monday.

On valuation measures, Oasis Petroleum Inc. stock it’s trading at a forward P/E multiple of 29.89x, and at a multiple of 2.71x this year’s estimated earnings.  The t-12-month revenue at Oasis Petroleum Inc. is $1.39 billion. OAS ‘s ROE for the same period is 31.48%.

Shares of the $1.40 billion market cap company are down 66.37% year-over-year  and 13.36% year-to-date.

Oasis Petroleum Inc., currently with a median Wall Street price target of $18.00 and a high target of $41.00, dropped $0.63 to $13.70 in recent trading.

The chart below shows where the equity has traded over the past 52-weeks., inc. (CRM) was downgraded from ‘Buy‘ to ‘Hold‘ at Argus.

Shares have traded today between $66.67 and $68.80 with the price of the stock fluctuating between $48.18 to $71.00 over the last 52 weeks. Inc. shares are currently changing hands at 74.50x fiscal 2017 forecasted earning. Ticker has a t-12 price/sales ratio of 8.23. EPS for the same period registers at  ($0.42).

Shares of CRM have lost $1.21 to $68.17 in mid-day trading on Monday, giving it a market cap of roughly $43.44 billion. The stock traded as high as $71.00 in Feb 26, 2015.

Sun Trust Rbsn Humphrey reported on Monday that they have lowered their rating for Northern Oil and Gas, Inc. (NOG). The firm has downgraded NOG from ‘Buy‘ to ‘Neutral‘.

Northern Oil & Gas Inc. recently traded at $7.82, a loss of $0.80 over Friday’s closing price. The name has a current market capitalization of $473.21 million.

Sucampo Pharmaceuticals, Inc. (SCMP) had its rating lowered from ‘Neutral‘ to ‘Underperform‘ by analysts at Credit Suisse (CS) on Monday. The firm sees shares as fairly valued at $13 versus $15.38 close. Currently there are 4 analysts that rate SCMP a ‘Buy’. No analyst rates it a ‘Sell’.

SCMP was down $1.97 at $13.41 in mid-day trade, moving within a 52-week range of $5.80 to $16.54. The name, valued at $587.43 million, opened at $14.81.

On valuation measures, Sucampo Pharmaceuticals Inc. Cl A shares are currently priced at 103.95x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 6.73. EPS for the same period registers at $0.13.

International Business Machines Corp. (IBM) was downgraded from analysts at Atlantic Equities from a ‘Neutral‘ rating to an ‘Underweight‘ rating in a research report issued to clients on Monday.

IBM closed at $161.94 on Friday and is currently trading down $1.26.

In the past 52 weeks, shares of the tech company have traded between a low of $149.52 and a high of $199.21 and are now trading at $160.68. Shares are down 10.33% year-over-year ; up 1.64% year-to-date.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.